Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination therapy for visceral leishmaniasis.
van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. van Griensven J, et al. Among authors: alvar j. Lancet Infect Dis. 2010 Mar;10(3):184-94. doi: 10.1016/S1473-3099(10)70011-6. Lancet Infect Dis. 2010. PMID: 20185097 Review.
Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J. Bern C, et al. Among authors: alvar j. Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28. Clin Infect Dis. 2006. PMID: 16941377
Developments in the treatment of visceral leishmaniasis.
den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M. den Boer ML, et al. Among authors: alvar j. Expert Opin Emerg Drugs. 2009 Sep;14(3):395-410. doi: 10.1517/14728210903153862. Expert Opin Emerg Drugs. 2009. PMID: 19708817 Free article. Review.
Visceral leishmaniasis: elimination with existing interventions.
Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J. Matlashewski G, et al. Among authors: alvar j. Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Lancet Infect Dis. 2011. PMID: 21453873 Review.
The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis.
Wasunna M, Musa A, Hailu A, Khalil EA, Olobo J, Juma R, Wells S, Alvar J, Balasegaram M. Wasunna M, et al. Among authors: alvar j. Trans R Soc Trop Med Hyg. 2016 Jun;110(6):321-3. doi: 10.1093/trstmh/trw031. Epub 2016 Jun 7. Trans R Soc Trop Med Hyg. 2016. PMID: 27268714 Free PMC article.
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
Kimutai R, Musa AM, Njoroge S, Omollo R, Alves F, Hailu A, Khalil EA, Diro E, Soipei P, Musa B, Salman K, Ritmeijer K, Chappuis F, Rashid J, Mohammed R, Jameneh A, Makonnen E, Olobo J, Okello L, Sagaki P, Strub N, Ellis S, Alvar J, Balasegaram M, Alirol E, Wasunna M. Kimutai R, et al. Among authors: alvar j. Clin Drug Investig. 2017 Mar;37(3):259-272. doi: 10.1007/s40261-016-0481-0. Clin Drug Investig. 2017. PMID: 28066878 Free PMC article.
162 results